The Evolution of Canaloplasty - Summary - MDSpire
Feature

The Evolution of Canaloplasty

Share

Recent advancements in glaucoma surgery focus on improving the function of Schlemm’s canal through novel implantable bioscaffolds and dilation techniques. Traditional methods like viscocanalostomy have shown limited results, but the evolution towards canaloplasty—a procedure that includes dilating the canal and reinforcing it with scaffolding—has gained traction since its introduction around 2008. New ab interno techniques promise enhanced safety and efficacy, leading to better intraocular pressure reduction and expanding treatment options for glaucoma patients.

Original Source(s)

The Evolution of Canaloplasty

  • by John S. McInnes, MD, JD, Nathan M. Radcliffe, MD, Cynthia Mattox, MD

  • May 1, 2026

Related Content

GA Gene Therapy Interest Increases

Phase I trial results of PulseSight Therapeutics’ PST-611 to be presented at ARVO 2026

  • May 1, 2026

  • 2 min
Ocugen GA Trial Advances Toward Phase 3

Ocugen reports positive Phase 2 data for its OCU410 gene therapy in geographic atrophy

  • May 1, 2026

  • 3 min
TULIP: A New Approach to IOP Reduction

Low-power ultrasound biomodulation may offer a noninvasive, repeatable strategy to lower IOP without tissue destruction.